3.02
0.01%
0.00
前日終値:
$3.02
開ける:
$3.05
24時間の取引高:
7,500
Relative Volume:
0.03
時価総額:
$118.95M
収益:
$63.15M
当期純損益:
$-40.30M
株価収益率:
-1.3422
EPS:
-2.25
ネットキャッシュフロー:
$-44.47M
1週間 パフォーマンス:
+3.43%
1か月 パフォーマンス:
+1.01%
6か月 パフォーマンス:
-34.48%
1年 パフォーマンス:
-54.38%
Tela Bio Inc Stock (TELA) Company Profile
名前
Tela Bio Inc
セクター
電話
484-320-2930
住所
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
TELA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
3.02 | 118.95M | 63.15M | -40.30M | -44.47M | -1.67 |
ABT
Abbott Laboratories
|
113.56 | 196.18B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
360.10 | 137.26B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
89.73 | 131.64B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
80.33 | 102.43B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
73.30 | 43.66B | 6.60B | 4.16B | 490.10M | 6.93 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2022-05-31 | 開始されました | Lake Street | Buy |
2019-12-03 | 開始されました | Canaccord Genuity | Buy |
2019-12-03 | 開始されました | JMP Securities | Mkt Outperform |
2019-12-03 | 開始されました | Jefferies | Buy |
2019-12-03 | 開始されました | Piper Jaffray | Overweight |
Tela Bio Inc (TELA) 最新ニュース
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3% – Here’s Why - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3%Should You Sell? - MarketBeat
TELA Bio Announces Inducement Grants for New Employees - MSN
TELA Bio's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
TELA Bio's SWOT analysis: stock poised for growth amid challenges - Investing.com
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Awards Strategic Inducement Grants to Secure Key New Talent - StockTitan
The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable - Yahoo Finance
Earnings call: TELA Bio reports strong Q3 growth, eyes future gains - Investing.com Nigeria
TELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 29.8% in November - MarketBeat
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
GSA Capital Partners LLP Purchases 89,712 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio to Present at Canaccord Genuity’s Growth Conference - MSN
TELA Bio Reports Strong Revenue Growth in Q3 2024 - MSN
TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - The Manila Times
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference - GlobeNewswire
TELA Bio's SWOT analysis: innovative medical device stock faces growth hurdles - Investing.com India
TELA Bio, Inc. (NASDAQ:TELA) Sees Large Decline in Short Interest - MarketBeat
TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Call Transcript - Insider Monkey
TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely - Simply Wall St
TELA Bio stock target cut, keeps overweight rating on Q3 results - Investing.com Nigeria
TELA Bio Inc (TELA) Quarterly 10-Q Report - Quartzy
Tela Bio price target lowered to $5 from $8 at Piper Sandler - TipRanks
Deep Dive Into TELA Bio Stock: Analyst Perspectives (6 Ratings) - Benzinga
Piper Sandler Has Lowered Expectations for TELA Bio (NASDAQ:TELA) Stock Price - MarketBeat
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates - MSN
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
TELA Bio, Inc. Reports Record Revenue Growth - TipRanks
TELA Bio Inc Q3 2024 Earnings: Revenue Hits $19M, EPS at -$0.42, - GuruFocus.com
Tela Bio earnings missed by $0.02, revenue topped estimates - Investing.com UK
TELA Bio Reports Third Quarter 2024 Financial Results - The Manila Times
What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings - GuruFocus.com
TELA Bio Announces Inducement Grants of Restricted Stock Units to New Employees - MSN
TELA Bio (TELA) to Release Quarterly Earnings on Thursday - MarketBeat
Tela Bio Commercially Launches OviTex IHR in the US - MPO-mag
Tela Bio Inc (TELA) 財務データ
収益
当期純利益
現金流量
EPS
Tela Bio Inc (TELA) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
ORBIMED ADVISORS LLC | 10% Owner |
Jun 28 '24 |
Sale |
4.74 |
378,000 |
1,791,720 |
2,457,542 |
ORBIMED ADVISORS LLC | 10% Owner |
Jul 02 '24 |
Sale |
4.54 |
36,600 |
166,164 |
2,407,242 |
ORBIMED ADVISORS LLC | 10% Owner |
Jul 01 '24 |
Sale |
4.68 |
13,700 |
64,116 |
2,443,842 |
大文字化:
|
ボリューム (24 時間):